Antibodies targeting the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
present a promising approach to combat the coronavirus disease 2019 (COVID…

An urgent global quest for effective therapies to prevent and treat coronavirus disease 2019
(COVID-19) is ongoing. We previously described REGN-COV2, a cocktail of two potent …

Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option
against COVID-19. Because rapidly emerging virus mutants are becoming the next major …

Non-human primate models will expedite therapeutics and vaccines for coronavirus
disease 2019 (COVID-19) to clinical trials. Here, we compare acute severe acute respiratory …

IFN-γ is a key cytokine controlling Brucella infection. One of its major function is the
stimulation of Brucella-killing effector mechanisms, such as inducible NO synthase (iNOS)/NOS2 …

Pathogens that evade adaptive immunity typically exhibit antigenic variation. By contrast, it
appears that although the chronic human tuberculosis (TB)-causing pathogen Mycobacterium …

Brucella are facultative intracellular bacteria that chronically infect humans and animals
causing brucellosis. Brucella are able to invade and replicate in a broad range of cell lines in …

The Mycobacterium tuberculosis genome includes the large family of pe_pgrs genes, whose
functions are unknown. Because of precedents in other pathogens in which gene families …

The past two decades have witnessed an alarming expansion of staphylococcal disease
caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). The …

The epidemic community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
USA300 lineage has recently become a leading cause of hospital-associated bloodstream …